News
- Author:
- Michele G. Sullivan
Publish date: March 16, 2018
The presence of an antibody to chlamydia increased the chance of ovarian cancer by up to 2.25-fold in case-control studies in Poland and the U.S.
News
- Author:
- Michele G. Sullivan
Publish date: March 14, 2018
Twenty-one separate variants in the ICK gene accounted for the cases.
News
- Author:
- Michele G. Sullivan
Publish date: March 7, 2018
The maternal HBV transmission rate was unexpectedly low in both the placebo and active groups.
News
- Author:
- Michele G. Sullivan
Publish date: March 7, 2018
Challenges include making it as easy as possible for clinicians to do and motivating patients to engage fully with treatment.
News
- Author:
- Michele G. Sullivan
Publish date: March 1, 2018
New tracks on managing alternative providers, palliative care offered.
News
- Author:
- Michele G. Sullivan
Publish date: February 25, 2018
SAN DIEGO – Questions remain about why some patients maintain durable response.
News
- Author:
- Michele G. Sullivan
Publish date: February 24, 2018
SAN DIEGO – The benefit may be a class-associated effect.
News
- Author:
- Michele G. Sullivan
Publish date: February 24, 2018
SAN DIEGO – The novel molecule, ASN002, inhibits Janus kinase and spleen tyrosine kinase.
News
- Author:
- Michele G. Sullivan
Publish date: February 21, 2018
Almost 60% of those taking 30 mg of the JAK1-selective inhibitor experienced 90% skin clearance in the phase 2b study.
News
- Author:
- Michele G. Sullivan
Publish date: February 19, 2018
Nearly 60% of those taking the investigational drug had cleared all lesions after 52 weeks of treatment.
Video
- Author:
- Michele G. Sullivan
Publish date: February 18, 2018
With T1-T2 tumors and a Class 1A test result, SLN positivity was 1.6% in patients 65 years and older.
News
- Author:
- Michele G. Sullivan
Publish date: February 15, 2018
DALLAS – Findings from Washington University, St. Louis, may help explain the consistently higher rates of spontaneous preterm birth among black wo...
News
- Author:
- Michele G. Sullivan
Publish date: February 15, 2018
DALLAS – A multigene skeletal dysplasia panel correctly predicted fetal lethality or viability in 75% of positive samples.
News
- Author:
- Michele G. Sullivan
Publish date: February 13, 2018
DALLAS – A 10-year retrospective review at one medical center looked for treatment changes due to CT results.
News
- Author:
- Michele G. Sullivan
Publish date: February 13, 2018
DALLAS – A clinical trial is the first step in challenging the widely accepted practice of automatic maternal oxygen.
